BioWorld MedTech

Dec. 10, 2013

View Archived Issues

Financings roundup: CareFusion to invest $100M in Israeli infusion pump maker

Harvard Bioscience reduces workforce, realigns operations

Agreements/contracts: LGT to co-develop Alar sensor with Xhale

Health Information Technology: Billings Clinic implements Omnicell, Cerner solution

Med-tech Briefs

New ventures: Companies form 3D Microprint to develop new MLS technoogy

Court report: BMC ready to defend itself against ResMed in patent suit

Deals roundup: Covidien in bid to acquire Given Imaging for $860M

In a move that's perhaps sending shock waves through the med-tech industry, Covidien (Dublin, Ireland) is saying that it will acquire Given Imaging (Yokneam, Israel) for $30 per share in cash, or a total of $860 million. Read More

ZOLL reports AZM unit Shonin approval for X Series products

People in Places

Product briefs

Hologic's board becomes crowded with Icahn allies

MDD's Cardiovascular Extra

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...